Topical therapy of balanitis xerotica obliterans in childhood: Long-term clinical results and an overview;Die topische therapie der balanitis xerotica obliterans im kindesalter: Klinische langzeitergebnisse und übersicht

Urologe - Ausgabe A

Volumn 46, Issue 12, 2007, Pages 1682-1686

  Ebert, A K ^a   Vogt, T ^b   Rosch W H ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Balanitis xerotica obliterans; BXO relapse; Childhood; Tacrolimus; Topical therapy

Indexed keywords

TACROLIMUS;

DRUG SAFETY; FOLLOW UP; HUMAN; IMMUNOMODULATION; INCIDENCE; LICHEN SCLEROSUS ET ATROPHICUS; PATIENT MONITORING; RETROSPECTIVE STUDY; REVIEW;

ADMINISTRATION, TOPICAL; ADOLESCENT; BALANITIS; BETAMETHASONE; CHILD; CHILD, PRESCHOOL; CIRCUMCISION, MALE; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HUMANS; MALE; PENIS; RECURRENCE; TACROLIMUS; URETHRAL STRICTURE;

EID: 36949008573     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-007-1577-1     Document Type: Review

References (22)

1. Bale PM, Lochhead A, Martin HCO, Gollow I (1987) Balanitis xerotica obliterans in children. Pediatr Pathol 7: 617-627
2. Böhm M, Frieling U, Luger A, Bonsmann G (2003) Successful treatment of anogenital Lichen sclerosus with topical tacrolimus. Arch Dermatol 139: 922-924
3. Cabaleiro P, Drut RM, Drut R (2000) Lymphohistiocytic and granulomatous phlebitis in penile lichen sclerosus. Am J Dermatopathol 22: 316-320
4. Clemmensen OJ, Krogh J, Petri M (1988) The histologic spectrum of prepuces from patients with phimosis. Am J Dermatopathol 10: 104-108
5. Clifton MM, Garner IB, Kohler S, Smoller BR (1999) Immunohistochemical evaluation of androgen receptors in genital and extragenital lichen sclerosus: Evidence for loss of androgen receptors in lesional epidermis. J Am Acad Dermatol 41: 43-46
6. Das S, Tunuguntla HS (2000) Balanitis xerotica obliterans - a review. World J Urol 18: 382-387
7. Depasquale I, Park AJ, Bracka A (2000) The treatment of balanitis xerotica obliterans. BJU Int 86: 459-464
8. Fischer G, Rogers M (1997) Treatment of childhood vulvar lichen sclerosus with potent topical corticosteroid. Pediatr Dermatol 14: 235-238
9. Garat JM, Chechile G, Algaba F, Santaularia JM (1986) Balanitis xerotica obliterans in children. J Urol 136: 436-437
10. Gargollo PC, Kozakewich HP, Bauer SB et al. (2005) Balanitis xerotica obliterans in boys. J Urol 174: 1409-1412
11. Hennge UR, Krause W, Hofmann H et al. (2006) Multicentre, phase II trial on safety and efficacy of topical tacrolimus oinment for the treatment of lichen sclerosus. Br J Dermatol 155: 1021-1028
12. Herschorn S, Colapinto V (1979) Balanitis xerotica obliterans involving anterior urethra. Urology 14: 592-596
13. Mattioli G, Repetto P, Carlini C et al. (2002) Lichen sclerosus et atrophicus in children with phimosis and hypospadias. Pediatr Surg Int 18: 273-275
14. McLelland J (2004) Lichen sclerosus in children. J Obstet Gynaecol 24: 733-735
15. Meffert JJ, Davis BM, Grimwood RE (1995) Lichen sclerosus. J Am Acad Dermatol 32: 393-416
16. Pietrzak P, Hadway P, Corbishley CM, Watkin NA (2006) Is the association between balanitis xerotica obliterans and penile carcinoma underestimated? BJU Int 98: 74-76
17. Poynter JH, Levy J (1967) Balanitis xerotica obliterans: effective treatment with topical and sublesional corticosteroids. BJU Int 39: 420-425
18. Powell J, Wojnarowska F, Winsey S et al. (2000) Lichen sclerosus premenarche: autoimmunity and immunogenetics. Br J Dermatol 142: 481-484
19. Produktmonographie (2002) Protopic© Tacrolimussalbe 0,03%/0,1%. Dermatology, München
20. Rallis E, Korfitis C, Gregoriou S et al. (2007) Assigning new roles to topical tacrolimus. 16: 1267-1276
21. Staff WG (1970) Urethral involvement in Balanitis xerotica obliterans. BJU Int 47: 234-239
22. Stühmer A (1928) Balanitis xerotica obliterans (post operationem) und ihre Beziehung zur Kraurosis glandis et praeputii penis. Arch Derm Syph 156: 613-623